Literature DB >> 27869169

Critical role of the POT1 OB domain in maintaining genomic stability.

T K Pandita1.   

Abstract

Oligonucleotide/oligosaccharide-binding (OB) domain-containing proteins have been identified as critical for telomere maintenance, DNA repair, transcription and other DNA metabolism processes. Protection of telomere 1 (POT1), a telomere binding protein, has an OB domain like single-strand binding protein (SSB1). In this issue of Oncogene, Gu et al. present evidence that POT1, like SSB1, is required to maintain genomic stability. This work, in conjunction with results from previous investigators, highlights the importance of POT1 in telomere metabolism. Inactivation of POT1 telomere protective functions in mouse models lacking p53 expression in the breast epithelium unleashes a torrent of DNA damage responses (DDRs) at the telomeres, culminating in karyotypic alterations with massive arrays of telomere fusions. Therefore, POT1 is not only required to promote telomere homeostasis, but also plays an essential role in maintaining a stable genome.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27869169     DOI: 10.1038/onc.2016.365

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  48 in total

1.  p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis.

Authors:  L Chin; S E Artandi; Q Shen; A Tam; S L Lee; G J Gottlieb; C W Greider; R A DePinho
Journal:  Cell       Date:  1999-05-14       Impact factor: 41.582

2.  PTOP interacts with POT1 and regulates its localization to telomeres.

Authors:  Dan Liu; Amin Safari; Matthew S O'Connor; Doug W Chan; Andrew Laegeler; Jun Qin; Zhou Songyang
Journal:  Nat Cell Biol       Date:  2004-06-06       Impact factor: 28.824

3.  Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC.

Authors:  Tom Vulliamy; Anna Marrone; Richard Szydlo; Amanda Walne; Philip J Mason; Inderjeet Dokal
Journal:  Nat Genet       Date:  2004-04-18       Impact factor: 38.330

4.  p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2.

Authors:  J Karlseder; D Broccoli; Y Dai; S Hardy; T de Lange
Journal:  Science       Date:  1999-02-26       Impact factor: 47.728

5.  POT1 and TRF2 cooperate to maintain telomeric integrity.

Authors:  Qin Yang; Yun-Ling Zheng; Curtis C Harris
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

6.  POT1b protects telomeres from end-to-end chromosomal fusions and aberrant homologous recombination.

Authors:  Hua He; Asha S Multani; Wilfredo Cosme-Blanco; Hidetoshi Tahara; Jin Ma; Sen Pathak; Yibin Deng; Sandy Chang
Journal:  EMBO J       Date:  2006-10-19       Impact factor: 11.598

7.  Structure of human POT1 bound to telomeric single-stranded DNA provides a model for chromosome end-protection.

Authors:  Ming Lei; Elaine R Podell; Thomas R Cech
Journal:  Nat Struct Mol Biol       Date:  2004-11-21       Impact factor: 15.369

Review 8.  Cancer in dyskeratosis congenita.

Authors:  Blanche P Alter; Neelam Giri; Sharon A Savage; Philip S Rosenberg
Journal:  Blood       Date:  2009-03-12       Impact factor: 22.113

9.  Human telomeres are attached to the nuclear matrix.

Authors:  T de Lange
Journal:  EMBO J       Date:  1992-02       Impact factor: 11.598

10.  Dysfunctional telomeres activate an ATM-ATR-dependent DNA damage response to suppress tumorigenesis.

Authors:  Xiaolan Guo; Yibin Deng; Yahong Lin; Wilfredo Cosme-Blanco; Suzanne Chan; Hua He; Guohua Yuan; Eric J Brown; Sandy Chang
Journal:  EMBO J       Date:  2007-10-18       Impact factor: 14.012

View more
  1 in total

1.  POT1 inhibits the efficiency but promotes the fidelity of nonhomologous end joining at non-telomeric DNA regions.

Authors:  Yang Yu; Rong Tan; Qian Ren; Boya Gao; Zhejin Sheng; Juanlian Zhang; Xiaoqing Zheng; Ying Jiang; Li Lan; Zhiyong Mao
Journal:  Aging (Albany NY)       Date:  2017-12-08       Impact factor: 5.955

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.